This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue up 19.3% year on year; profit after tax Rs 36.08 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended 30 September 2026 show revenue from operations of Rs 2,133.01 lakh, up 19.3% from Rs 1,787.50 lakh a year earlier, while profit after tax was nearly flat at Rs 36.08 lakh versus Rs 36.09 lakh. Operating profit before other income, interest, tax, depreciation and amortisation was about 5.7% of revenue, versus 6.8%, down 1.1 percentage points. The limited review found no material misstatement.
Revenue growth did not lift profit, while margins weakened, indicating near-term pressure on earnings despite a clean limited review.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹21.33 Cr | ₹17.88 Cr | +19.3% |
| Operating profit | ₹0.39 Cr | ₹0.32 Cr | +24.7% |
| Profit after tax | ₹0.36 Cr | ₹0.36 Cr | −0.2% |
| EBITDA margin | 5.7% | 6.8% | −1.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.